0001231919-26-001227.txt : 20260928 0001231919-26-001227.hdr.sgml : 20260928 20260925213034 ACCESSION NUMBER: 0001231919-26-001227 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260928 DATE AS OF CHANGE: 20260925 EFFECTIVENESS DATE: 20260928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alpfa Medical, Inc. CENTRAL INDEX KEY: 0002156252 ORGANIZATION NAME: EIN: 872913462 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-598962 FILM NUMBER: 261411826 BUSINESS ADDRESS: STREET 1: 1880 EMBARCADERO ROAD CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: (669) 257-3263 MAIL ADDRESS: STREET 1: 1880 EMBARCADERO ROAD CITY: PALO ALTO STATE: CA ZIP: 94303 D 1 primary_doc.xml X0708 D LIVE 0002156252 Alpfa Medical, Inc. 1880 EMBARCADERO ROAD PALO ALTO CA CALIFORNIA 94303 (669) 257-3263 DELAWARE Squirrel Corporation None Corporation true 2021 Allan Zingeler c/o Alpfa Medical, Inc. 1880 Embarcadero Road Palo Alto CA CALIFORNIA 94303 Executive Officer Director David Bonita c/o Alpfa Medical, Inc. 1880 Embarcadero Road Palo Alto CA CALIFORNIA 94303 Director Andrew ElBardissi c/o Alpfa Medical, Inc. 1880 Embarcadero Road Palo Alto CA CALIFORNIA 94303 Director Michael Hurley c/o Alpfa Medical, Inc. 1880 Embarcadero Road Palo Alto CA CALIFORNIA 94303 Director Michael Kramer c/o Alpfa Medical, Inc. 1880 Embarcadero Road Palo Alto CA CALIFORNIA 94303 Director Raju Viswanathan c/o Alpfa Medical, Inc. 1880 Embarcadero Road Palo Alto CA CALIFORNIA 94303 Director Michael Wiley c/o Alpfa Medical, Inc. 1880 Embarcadero Road Palo Alto CA CALIFORNIA 94303 Executive Officer Director Rupa Patel c/o Alpfa Medical, Inc. 1880 Embarcadero Road, Palo Alto, CA 943 Palo Alto CA CALIFORNIA 94303 Executive Officer Other Health Care Decline to Disclose 06b false 2026-09-11 true true true Offering of preferred stock and the underlying common stock issuable upon conversion of the preferred stock. false 0 100268055 80268077 19999978 Series B-1 + Series B-2 Preferred Stock and the Common Stock issuable upon conversion thereof. Includes $30,268,087in value of cancelled convertible instruments. The remaining $19,999,978 of the total offering amount reserved for future milestone closings false 71 0 0 0 false Alpfa Medical, Inc. /s/ Allan Zingeler Allan Zingeler Chief Executive Officer 2026-09-25